[A role of PPARgamma in reproduction?].
Synthetic molecules of the glitazone family are currently used in the treatment of type II diabetes. Glitazones also improve secondary pathologies that are frequently associated with insulin resistance such as the polycystic ovary syndrome (PCOS). Glitazones bind to the peroxysome proliferator-activated receptor gamma (PPARgamma), a nuclear receptor which is highly expressed in adipose tissue. PPARgamma also binds natural ligands such as long-chain fatty acids. Recently, several groups have shown that PPARgamma is also highly expressed in ovarian granulosa cells, and that glitazones are able to modulate in vitro granulosa cell proliferation and steroidogenesis in several species. These recent data raise new questions concerning the underlying mechanism of the effect of glitazones on PCOS. One might hypothesize, as for other << glucophage >> molecules such as metformin, that it is the general improvement of glucose metabolism and insulin sensitivity by glitazones which indirectly, and via an unknown mechanism, ameliorates ovarian functionality. The data discussed here suggest now an alternative possibility, that glitazones act directly at the ovarian level. Moreover, PPARgamma also seems to play a key role in the maturation of the placenta. In particular, inactivation of PPARgamma in mice is lethal, since the foetus is unable to develop because of alterations of placental maturation. In women, the activation of PPARgamma in placenta leads to an increase of placental hormone secretion. Overall, these results raise some questions about the role of natural ligands of PPARgamma such as long chain fatty acids on female fertility and the interactions between energy metabolism and reproduction in general.
Froment
Pascal
P
LMBC, Department for Molecular Biomedical Research, VIB, Technologiepark 927, B-9052 Gand (Zwijnaarde), Belgique. pascalf@dmbr.ugent.be
Gizard
Florence
F
Staels
Bart
B
Dupont
Joëlle
J
Monget
Philippe
P
D000818:Animals; D047108:Embryonic Development; D005260:Female; D006801:Humans; D008297:Male; D047495:PPAR gamma / Q000502:physiology*; D011085:Polycystic Ovary Syndrome / Q000188:drug therapy; D012098:Reproduction / Q000502:physiology*; D045162:Thiazolidinediones / Q000627:therapeutic use
D047495:PPAR gamma; D045162:Thiazolidinediones